<DOC>
	<DOCNO>NCT01218165</DOCNO>
	<brief_summary>Cardiovascular disease ( CVD ) main cause death European Union . A large part age process , include immunosenescence , explain imbalance inflammatory anti-inflammatory network , wich result low grade chronic pro-inflammatory status term inflammaging . It contribute number age-related chronic disease ( e.g . atherosclerosis , type 2 diabetes , Alzheimer disease , osteoporosis ) . Prevention delay onset chronic disease potentially benefit large segment elderly population . Now hypothesise probiotic drink reduce low-grade inflammation improvement gut barrier function gut microbiota composition elderly people low-grade inflammation .</brief_summary>
	<brief_title>Low Grade Inflammation , Gut Microbiota Barrier Function Elderly Humans</brief_title>
	<detailed_description>Cardiovascular disease ( CVD ) main cause death European Union . A large part age process , include immunosenescence , explain imbalance inflammatory anti-inflammatory network , wich result low grade chronic pro-inflammatory status term inflammaging . It contribute number age-related chronic disease ( e.g . atherosclerosis , type 2 diabetes , Alzheimer disease , osteoporosis ) . Prevention delay onset chronic disease potentially benefit large segment elderly population . Now hypothesise probiotic drink reduce low-grade inflammation improvement gut barrier function gut microbiota composition elderly people low-grade inflammation .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Men &gt; 65 year age . Body mass index : 2234,9 kg/mÂ² nonsmoker Intervention trial : hsCRP &gt; 1 mg/L ( Screening blood test ) normal blood count ( Screening blood test ) normal ALAT , ASAT serum creatinine level ( Screening blood test ) major nonorganic disease , include malign disease ( haematological , inflammatory , metabolic , ) major organ disease , include neoplastic disease . intake antibiotic within last 6 week chronic therapy analgetics ( incl . acetylsalicylic acid ) chronic therapy proton pump inhibitor regular intake probiotic bacteria product within last 3 week chronic antiinflammatory therapy NSARs previous therapy within last 20 day subject expect noncompliance protocol guideline subject participate trial</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Healthy Eldery People</keyword>
</DOC>